Mutations affecting nitrogen-source utilization alter rapamycin toxicity. (A) Isogenic wild-type (MLY41) and Δgln3 (MLY139), Δure2 (MLY140a), Δnpr1 (MLY54a), npi1 (MLY141a), and fpr1 (MLY88) mutant strains were grown on YPD medium containing 0, 10, or 50 ng/ml rapamycin and incubated for 3 days at 30°C. (B) Isogenic wild-type (MLY41) and Δure2 (MLY140a), TOR2-1 (MLY152α), TOR2-1 Δure2 (MLY158α), TOR1-4 (MLY90-1), TOR1-4 Δure2 (MLY148α), fpr1 (MLY88), and fpr1 Δure2 (MLY146a) mutant strains were grown on YPD medium containing 0 or 100 ng/ml rapamycin and incubated for 3 days at 30°C.